Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study

Journal of Neuro-Oncology

Volumn 43, Issue 2, 1999, Pages 161-166

  Lassen, Ulrik ^a,b   Kristjansen, Paul E G ^a   Wagner, Aase ^a   Kostel janetz, Michael ^a   Poulsen, Hans Skovgaard ^a  

^a Rigshospitalet   (Denmark)

^b FINSEN LABORATORY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; ETOPOSIDE;

ADULT; AGED; ARTICLE; BLEEDING; CANCER GRADING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEBRILE NEUTROPENIA; FEMALE; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NEPHROTOXICITY; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; REMISSION; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; ETOPOSIDE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY; SURVIVAL ANALYSIS;

EID: 0032877837     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006254716877     Document Type: Article

References (17)

1. Vecht CJ, Avezaat CJJ, van Putten WLJ et al.: The influence of the extent of surgery on the neurologial function and survival in malignant glioma. A retrospective analysis in 243 patients. J Neur Neurosurg Neuropsych 53: 466-471, 1990
2. Medical Research Council Brain Tumour Working Group: Prognostic factors for high-grade malignant gliomas: Development of a prognostic index. J Neuro-Oncol 9: 47-55, 1990
3. Walker MD, Green SB, Byar DP et al.: Randomized comparison of radiotherapy and nitrosureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980
4. Fine HA, Dear KBG, Loeffler JS et al.: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1992
5. Jeremic B, Grujicic D, Jevremovic S et al.: Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study. J Clin Oncol 10: 1074-1077, 1992
6. Kiu M, Chang C, Cheng W et al.: Combination chemotherapy with carmustine and cisplatin before, during, and after radiotherapy for adult malignant gliomas. J Neuro-Oncol 25: 215-220, 1995
7. Fulton D, Urtasun R, Forsyth P: Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma. J Neuro-Oncol 27: 149-155, 1996
8. Sanson M, Ameri A, Monjour A et al.: Treatment of recurrent malignant supratentorial gliomas with ifosfamide, carboplatin and etoposide: a phase II study. Eur J Cancer 32a: 2229-2235, 1996
9. Grossman SA, Wharam M, Sheidler V et al.: Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma. J Clin Oncol 15: 2596-2603, 1997
10. Forsyth PAJ, Petrov E, Mahallati H et al.: Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas. J Clin Oncol 15: 2076-2082, 1997
11. Macdonald DR, Cascino TL, Schold SC et al.: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280, 1990
12. Lagrange JL, Bondiau PY, Tessier E et al.: Tumoral platinum concentrations in patients treated with low-dose cisplatin as a radiosensitizer. Int J Cancer 68: 452-456, 1996
13. Chisholm RA, Stenning S, Hawkins TD: The accuracy of volumetric measurement of high-grade gliomas. Clin Oncol 40: 17-21, 1989
14. Curran WJ, Scott CB, Horton J et al.: Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85: 704-710, 1993
15. Stea B, Kittelson J, Cassady JR, Hamilton A, Guttikelch N, Lulu B, Obbens F, Rossman K, Shapiro W, Shetter A et al.: Treatment of malignant gliomas with interstitial irradiation and hyperthermia. Int J Radiat Oncol Biol Phys 24: 657-667, 1992
16. Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL, Gutin PH: Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40: 287-295, 1998
17. Kirby S, Macdonald DR, Fisher B et al.: Pre-radiation chemotherapy for malignant gliomas in adults. Can J Neurol Sci 23: 123-127, 1996